Cillian is a Business Development and Product Manager at ERS Genomics, specializing in CRISPR/Cas9 licensing. With a background in biochemistry, genetics, and immunology, he has an MSc in Immunology from Trinity College Dublin and a BSc in Pharmaceutical Science and Drug Design. He excels in bridging the gap between scientific research and commercial applications, driving company growth and expanding CRISPR/Cas9 technology’s reach. Cillian’s talent for simplifying complex scientific concepts makes advanced technology accessible to diverse audiences. Passionate about the immune system, pathogen immunology, mechanisms, and genetics, Cillian explores cutting-edge innovations in gene editing and biotechnology. His academic research on mitochondrial reactive oxygen species, inflammasomes, and IL-1b secretion investigated ROS’s impact on genetic immune pathways, contributing to the understanding of inflammation and immune system function.